SOPHiA GENETICS (SOPH) Net Cash Flow (2020 - 2025)

SOPHiA GENETICS (SOPH) has 6 years of Net Cash Flow data on file, last reported at -$12.0 million in Q4 2025.

• For the quarter ending Q4 2025, Net Cash Flow rose 7.13% year-over-year to -$12.0 million; the trailing twelve-month figure through Dec 2025 stood at -$14.2 million (up 63.51% YoY), and the FY2025 full-year result was -$14.2 million, up 63.51% from the prior year.
• Net Cash Flow climbed to -$12.0 million in Q4 2025, from -$13.3 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $168.8 million in Q3 2021 to a low of -$20.8 million in Q3 2022.
• A 5-year average of -$156050.0 and a median of -$12.2 million in 2021 frame the typical range for Net Cash Flow.
• Across the five-year window, Net Cash Flow plunged 1915.5% in 2023 and soared 1596.8% in 2025, its largest moves.
• Tracing SOPH's Net Cash Flow over 5 years: stood at -$17.2 million in 2021, then jumped by 103.42% to $587000.0 in 2022, then sank by 1915.5% to -$10.7 million in 2023, then declined by 21.54% to -$13.0 million in 2024, then advanced by 7.13% to -$12.0 million in 2025.
• Business Quant data shows SOPH's Net Cash Flow at -$12.0 million in Q4 2025, -$13.3 million in Q3 2025, and $23.9 million in Q2 2025.